Skip to main content
Daily Report

Daily Cosmetic Research Analysis

02/11/2026
3 papers selected
15 analyzed

Analyzed 15 papers and selected 3 impactful papers.

Summary

A split-hand randomized double-blind trial found no clinical advantage to diluting calcium hydroxyapatite filler with a polymicronutrient solution despite enhanced in vitro fibroblast activity. Methodologically, an in vitro permeation study supports reconstructed full-thickness human skin (EpiDermFT) as a reliable alternative to cadaver skin for sunscreen testing. Occupational biomonitoring revealed higher urinary phenolic compounds among female beauty-salon workers versus household controls.

Research Themes

  • Aesthetic injectables and biostimulation optimization
  • In vitro skin models for sunscreen permeation and regulatory science
  • Occupational exposure to cosmetic-related phenolic chemicals

Selected Articles

1. Calcium Hydroxyapatite and Polymicronutrient Solution on Hand Rejuvenation: A Split-Hand, Randomized, Double-Blind Clinical and In Vitro Study.

68Level IIRCT
Journal of cosmetic dermatology · 2026PMID: 41669823

In vitro, CaHA diluted with a polymicronutrient solution increased fibroblast proliferation and upregulated ECM genes (COL1A1, ELN) versus saline dilution. Clinically, both CaHA+PMN and CaHA+saline improved hand appearance, hydration, and dermal thickness without between-group differences through 90 days.

Impact: This split-hand randomized double-blind study provides controlled clinical evidence challenging the added value of PMN dilution with CaHA despite mechanistic signals, guiding formulation choices in aesthetic practice.

Clinical Implications: For hand rejuvenation with CaHA, saline dilution appears to perform similarly to PMN dilution clinically; PMN-enhanced biological activity alone may not justify added complexity or cost without demonstrated patient-level benefits.

Key Findings

  • CaHA+PMN increased fibroblast proliferation and upregulated COL1A1 and ELN versus CaHA+saline in vitro.
  • Both formulations significantly improved Hand Grading Scale, skin hydration, and dermal/hypodermal thickness from baseline (p<0.001).
  • No statistically significant between-group differences were observed in clinical endpoints, GAIS, or patient satisfaction up to 90 days.

Methodological Strengths

  • Split-hand, randomized, double-blind design minimizing inter-individual variability.
  • Combined mechanistic (in vitro) and clinical endpoints with objective measures (ultrasound, corneometry).

Limitations

  • Small sample size (n=22) with 90-day follow-up may be underpowered to detect modest differences.
  • Single-center study; generalizability to broader populations and longer-term outcomes is uncertain.

Future Directions: Larger, multicenter RCTs with longer follow-up should assess durability, dosing, and cost-effectiveness of PMN dilution and include histologic/biomarker correlates.

BACKGROUND: Calcium hydroxyapatite (CaHA) is a well-established biostimulatory filler approved for hand rejuvenation. Recent approaches have explored dilution with polymicronutrient (PMN) solutions to enhance cellular metabolism and extracellular matrix (ECM) regeneration. AIMS: To evaluate the biological and clinical effects of CaHA diluted in a PMN solution (CaHA + PMN) compared with the conventional CaHA diluted in saline solution (CaHA + SS) for hand rejuvenation. METHODS: An in vitro study was conducted to assess fibroblast proliferation and gene expression of ECM components (COL1A1, COL3A1, and ELN) after exposure to CaHA diluted with PMN or SS. A prospective, split-hand, double-blind clinical trial (n = 22) compared both formulations regarding Hand Grading Scale (HGS), Global Aesthetic Improvement Scale (GAIS), skin hydration (corneometry), and dermal thickness (ultrasound imaging) at baseline, 15 and 90 days after treatment. RESULTS: In vitro, CaHA + PMN induced greater fibroblast proliferation and upregulated COL1A1 and ELN gene expression compared to CaHA + SS. Clinically, both treatments led to significant improvement from baseline in HGS (p < 0.001), skin hydration and dermal/hypodermal thickness, with no statistically significant differences between-group. Investigator-assessed GAIS and patient-reported satisfaction on a 5-point Likert scale also showed improvement in both groups. CONCLUSION: Both treatments demonstrated comparable clinical outcomes, suggesting that the strong biostimulating effect of CaHA may have overshadowed potential additive effects of PMN. Nonetheless, in vitro findings confirmed enhanced biological activity with CaHA + PMN, supporting its investigation as a complementary strategy in future studies.

2. In Vitro Permeation Testing of Sunscreens using Reconstructed Human Skin versus Human Cadaver Skin Models.

67Level VCase series
AAPS PharmSciTech · 2026PMID: 41667767

Reconstructed full-thickness human skin (EpiDermFT) yielded consistent intra- and inter-batch sunscreen permeation and mirrored the rank order seen with cadaver skin, supporting its use as an alternative barrier model. EpiDerm (without dermis) showed higher sensitivity to formulation pH, suggesting utility for detecting subtle formulation differences.

Impact: This study addresses critical supply and variability limitations of human skin in IVPT and provides methodological evidence to standardize sunscreen permeation testing using reproducible reconstructed models.

Clinical Implications: While not directly clinical, adopting EpiDermFT for permeation testing can improve consistency in formulation screening and regulatory submissions, potentially accelerating safer, more effective sunscreen development.

Key Findings

  • EpiDermFT (RHS with dermal layer) showed high intra- and inter-batch consistency in sunscreen permeation.
  • EpiDermFT preserved the rank order of cumulative permeation similar to cadaver skin.
  • EpiDerm (RHS without dermis) was more sensitive to formulation pH differences than HCS.

Methodological Strengths

  • Direct head-to-head comparison across four skin barrier models including cadaver and reconstructed tissues.
  • Assessed both reproducibility (intra-/inter-batch) and sensitivity to formulation variables (pH).

Limitations

  • Focused on sunscreen cream formulations; generalizability to other dosage forms remains to be shown.
  • Lacked in vivo correlation; translation to clinical protection outcomes is indirect.

Future Directions: Validate RHS across a broader array of topical dosage forms and active ingredients, and explore in vitro–in vivo correlations for regulatory acceptance.

In vitro permeation testing (IVPT) is a method widely used to assess the skin permeation profiles of topical drug products for product development and regulatory evaluation. Various skin models serve as diffusion barriers in IVPT, including surgically excised human skin (EHS) and human cadaver skin (HCS). Limited EHS supply has led to the use of HCS in IVPT, but HCS shows variable skin permeation among donors, creating challenges in obtaining consistent results. To address these supply and variability issues, this study evaluated the potential of reconstructed human skin (RHS) as an alternative diffusion barrier for IVPT. Sunscreen (cream) permeation through four skin models were compared, including two HCS models and two RHS models with or without dermal layers. Among the tested skin models, EpiDermFT (RHS with dermal layers) exhibited consistent results for both intra-batch and inter-batch permeation. Additionally, EpiDermFT exhibited similar rank order of cumulative permeation compared to the HCS counterpart, whereas EpiDerm (RHS without dermal layers) exhibited greater sensitivity to pH changes in cream formulations than HCS models. These findings suggest that EpiDermFT has potential utility as a reliable alternative that provides comparable permeation results to HCS, whereas EpiDerm may serve as a sensitive tool to detect pH differences in topical formulations. However, to determine the broader applicability of RHS in IVPT, further investigations using diverse topical formulations across different dosage forms are necessary.

3. Urinary levels of phenolic compounds in women working in beauty salons.

58.5Level IIICohort
Scientific reports · 2026PMID: 41667583

In a comparative biomonitoring study of 50 female beauticians and 35 household controls, urinary BPA, BP-1, BP-3, and triclosan were frequently detected and significantly higher among beauticians. Findings highlight occupational exposure risks associated with beauty-salon environments.

Impact: Provides human biomonitoring evidence of elevated exposure to phenolic chemicals among beauty-salon workers, informing occupational health policies in the cosmetic sector.

Clinical Implications: Clinicians should consider occupational sources when evaluating endocrine and dermatologic complaints in beauty workers and counsel on exposure reduction (e.g., ventilation, PPE, product selection).

Key Findings

  • Urinary BPA, BP-1, BP-3, and triclosan were frequently detected in female beauticians.
  • Beauticians had significantly higher urinary levels of these phenolic compounds than household controls.
  • Chromatographic analyses enabled quantification across two occupationally contrasted groups.

Methodological Strengths

  • Human biomonitoring with analytical quantification across exposed and control groups.
  • Occupationally relevant comparison enabling inference on workplace-related exposure.

Limitations

  • Cross-sectional design precludes causal inferences and temporal variability assessment.
  • Sample size is modest and potential confounders (diet, personal product use) are not detailed in the abstract.

Future Directions: Prospective studies incorporating detailed exposure histories, workplace assessments, and health outcomes are needed to link biomarker levels to risk and to evaluate mitigation strategies.

Several researches have reported considerable levels of phnolic compounds (bisphenol A (BPA), benzophenones (BP-1, BP-3) and triclosan (TCS)) in cosmetic/beauty products. However, there is limited data regarding the exposure of female beauticians to harmful substances. The present research aimed to evaluate the exposure of female salon workers to these pollutants by quantifying their urinary levels. To achieve this, 50 female beauticians were selected as the exposed group (EG) and a control group (CG) consisting of 35 housewives. Urine specimens were collected and analyzed by chromatographic techniques to determine the pollutants content. It was found that all pollutants (BPA, BP-1, BP-3 and TCS) were frequently detected in the urine samples of female beauticians. It was also observed that the levels of these contaminants in the samples collected from this occupational group was significantly higher than housewives (P